Albany Molecular Research (AMRI) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Recurring royalties: 1.06M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $75.1 million versus the consensus estimate of $81.5 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Rithm Capital earns S&P upgrade to ’B+’ following steady revenue diversification
- Moody’s raises BJ’s Wholesale outlook to positive on debt reduction
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
